TuHURA BIOSCIENCES, INC./NV Repayments of Notes Payable
TuHURA BIOSCIENCES, INC./NV (HURA) reported Repayments of Notes Payable of $1.50 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfNotesPayable · last filed 2026-03-31
- TuHURA BIOSCIENCES, INC./NV repayments of notes payable for the quarter ending 2025-12-31 was $1.40M.
- TuHURA BIOSCIENCES, INC./NV repayments of notes payable for fiscal 2025 was $1.50M.
| Period end | Repayments of Notes Payable 3 month | Repayments of Notes Payable 9 month | Repayments of Notes Payable 12 month |
|---|---|---|---|
| 2025-12-31 | $1.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $1.50M 10-K · filed 2026-03-31 | |
| 2025-09-30 | $98.68K 10-Q · filed 2025-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |